Pfizer PFE1.22%increase; green up pointing triangle shares tumbled to their lowest close in more than nine years, after the giant drugmaker overestimated Covid-19 vaccine use and the company was ...

Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need to know. Pfizer beat analysts’ revenue expectations by 3% last ...

Thousands of Pfizer PFE0.74%increase; green up pointing triangle employees from around the world were watching through their computer screens in October when Chief Executive Albert Bourla and ...

Pfizer's CEO said President Donald Trump's tariffs and uncertainty are holding the company back from making "tremendous investments" in the US. In a first-quarter earnings call on Tuesday, chief ...

Pfizer is pushing to be more involved in cancer drugs after a turbulent year marked by the rapid decline of its COVID business. During a four-hour investor event last week, Pfizer pushed its ...

Shares of Pfizer recently fell hard after the company announced full-year 2024 guidance. Pfizer also received regulatory approval to complete its proposed $43 billion acquisition of Seagen.

A former Pfizer employee and his close friend were arrested Thursday morning on charges they illegally used insider information about breakthrough results from the trial of the pharmaceutical ...

Oct 18 (Reuters) - Pfizer on Wednesday (PFE.N), opens new tab said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves to ...

Pfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the American pharmaceutical giant attempts to regain its footing as the COVID-19 pandemic subsides ...

Pfizer’s transition from pandemic reliance to growth in oncology and rare diseases reflects a strategic pivot, supported by recent acquisitions, despite the challenge of rising debt ...

March 16 (Reuters) - Pfizer Inc (PFE.N), opens new tab said on Thursday it was working on a new child-proof packaging for its migraine drug, Nurtec ODT, after safety concerns led to a recall alert ...

A 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according to a study by Stanford University researchers. Currently, there are no proven ...